HDAC5 and medulloblastoma: Recent studies have suggested that HDAC5 and HDAC9 are significantly upregulated in high-risk medulloblastoma in comparison with low-risk medulloblastoma and be associated with poor survival 6.It also has been reported that HDAC2 expression is significantly associated with CRC progression 7.